These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 19482474)
1. Outcome measures in Duchenne muscular dystrophy: are we ready for the new therapeutic era? Merkies IS; Faber CG Neuromuscul Disord; 2009 Jun; 19(6):447. PubMed ID: 19482474 [No Abstract] [Full Text] [Related]
2. Diagnosis and management of Duchenne muscular dystrophy. Baxter P Dev Med Child Neurol; 2010 Apr; 52(4):313. PubMed ID: 20412247 [No Abstract] [Full Text] [Related]
3. Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool. Scott E; Mawson SJ Dev Med Child Neurol; 2006 Jun; 48(6):540-4. PubMed ID: 16700951 [TBL] [Abstract][Full Text] [Related]
5. A new lease on life for patients with Duchenne muscular dystrophy in Japan. Yasuma F; Konagaya M; Sakai M; Kuru S; Kawamura T Am J Med; 2004 Sep; 117(5):363. PubMed ID: 15336589 [No Abstract] [Full Text] [Related]
6. Can outcomes in Duchenne muscular dystrophy be improved by public reporting of data? Peay HL; Scully MA; Cwik VA; Ciafaloni E; Griggs RC Neurology; 2013 Nov; 81(20):1802. PubMed ID: 24218315 [No Abstract] [Full Text] [Related]
7. Noninvasive ventilation during gastrostomy tube placement in patients with severe duchenne muscular dystrophy: case reports and review of the literature. Birnkrant DJ; Ferguson RD; Martin JE; Gordon GJ Pediatr Pulmonol; 2006 Feb; 41(2):188-93. PubMed ID: 16362975 [TBL] [Abstract][Full Text] [Related]
8. Duchenne muscular dystrophy: issues in expanding newborn screening. Kemper AR; Wake MA Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940 [TBL] [Abstract][Full Text] [Related]
9. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy. Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159 [TBL] [Abstract][Full Text] [Related]
10. New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Cossu G; Sampaolesi M Trends Mol Med; 2007 Dec; 13(12):520-6. PubMed ID: 17983835 [TBL] [Abstract][Full Text] [Related]
11. [Not Available]. Walter MC Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S24. PubMed ID: 26536187 [No Abstract] [Full Text] [Related]
13. Duchenne muscular dystrophy in a female child. Viswanathan V Indian Pediatr; 2002 Oct; 39(10):980-1; author reply 981. PubMed ID: 12428052 [No Abstract] [Full Text] [Related]
14. Antisense oligonucleotides in the treatment of Duchenne muscular dystrophy: Where are we now? Wilton SD; Fletcher S Neuromuscul Disord; 2005 Jun; 15(6):399-402. PubMed ID: 15907285 [No Abstract] [Full Text] [Related]
15. Muscular Dystrophy Campaign Funded Workshop on Management of Scoliosis in Duchenne Muscular Dystrophy 24 January 2005, London, UK. Muntoni F; Bushby K; Manzur AY Neuromuscul Disord; 2006 Mar; 16(3):210-9. PubMed ID: 16497502 [No Abstract] [Full Text] [Related]
16. Duchenne muscular dystrophy in a female child. Joshi S Indian Pediatr; 2002 Jan; 39(1):98. PubMed ID: 11805363 [No Abstract] [Full Text] [Related]
17. Holter electrocardiogram should be systematic in Duchenne muscular dystrophy. Fayssoil A Int J Cardiol; 2008 Aug; 128(3):442-3. PubMed ID: 17662485 [No Abstract] [Full Text] [Related]